3 completed, 1 terminated. 4 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 3, Terminated 1 |
| Phase 3 | 1 | Completed 1 |
Follow telcagepant: new trials by email Literature Review of telcagepant trials Research Report on telcagepant
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Telcagepant for Prevention of Menstrually Related Migraine in Female Participants With Episodic Migraine (MK-0974-065) Telcagepant, Placebo - Migraine | Phase 2 / Phase 3 | Completed | Merck Sharp & Dohme LLC | 4548 | 2010-06-01 | 2018-10-23 |
| A Study to Test the Safety and Effectiveness of MK-0974 (Telcagepant) Co-administered With Ibuprofen or Acetaminophen in Patients With Migraines With or Without Aura (MK-0974-046) placebo, ibuprofen, acetominophen - Migraine | Phase 2 | Completed | Merck Sharp & Dohme LLC | 683 | 2008-12-03 | 2018-10-22 |
| MK0974 (Telcagepant) for Migraine Prophylaxis in Patients With Episodic Migraine (0974-049) Telcagepant 140 mg, Telcagepant 280 mg, 140 mg telcagepant placebo - Migraine | Phase 2 | Terminated | Merck Sharp & Dohme LLC | 660 | 2008-11-12 | 2018-10-18 |
| A Dose-Finding Study of MK0974 in Acute Migraine (MK0974-004) Comparator: Placebo, MK0974, Rizatriptan - Migraine | Phase 2 | Completed | Merck Sharp & Dohme LLC | 420 | 2005-11-01 | 2015-11-02 |